TD Private Client Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Sell |
4,118
-2,107
| -34% | -$938K | 0.05% | 257 |
|
|
2025
Q1 | $3.02M | Buy |
6,225
+8
| +0.1% | +$3.88K | 0.08% | 174 |
|
|
2024
Q4 | $2.5M | Sell |
6,217
-7,470
| -55% | -$3.01M | 0.07% | 197 |
|
|
2024
Q3 | $6.37M | Buy |
13,687
+3,494
| +34% | +$1.62M | 0.18% | 84 |
|
|
2024
Q2 | $4.78M | Sell |
10,193
-2,623
| -20% | -$1.23M | 0.15% | 105 |
|
|
2024
Q1 | $5.36M | Sell |
12,816
-1,065
| -8% | -$445K | 0.18% | 93 |
|
|
2023
Q4 | $5.65M | Sell |
13,881
-1,216
| -8% | -$495K | 0.2% | 83 |
|
|
2023
Q3 | $5.25M | Sell |
15,097
-985
| -6% | -$343K | 0.23% | 86 |
|
|
2023
Q2 | $5.66M | Sell |
16,082
-1,073
| -6% | -$378K | 0.24% | 85 |
|
|
2023
Q1 | $5.41M | Buy |
17,155
+2,043
| +14% | +$644K | 0.24% | 93 |
|
|
2022
Q4 | $4.36M | Sell |
15,112
-149
| -1% | -$43K | 0.21% | 110 |
|
|
2022
Q3 | $4.42M | Sell |
15,261
-503
| -3% | -$146K | 0.23% | 102 |
|
|
2022
Q2 | $4.44M | Buy |
15,764
+4,750
| +43% | +$1.34M | 0.22% | 108 |
|
|
2022
Q1 | $2.87M | Buy |
11,014
+308
| +3% | +$80.4K | 0.12% | 177 |
|
|
2021
Q4 | $2.35M | Sell |
10,706
-649
| -6% | -$143K | 0.1% | 213 |
|
|
2021
Q3 | $2.06M | Buy |
11,355
+4,113
| +57% | +$746K | 0.09% | 227 |
|
|
2021
Q2 | $1.46M | Buy |
7,242
+6,516
| +898% | +$1.31M | 0.06% | 283 |
|
|
2021
Q1 | $156K | Sell |
726
-7,733
| -91% | -$1.66M | 0.01% | 533 |
|
|
2020
Q4 | $2M | Sell |
8,459
-1,962
| -19% | -$464K | 0.1% | 215 |
|
|
2020
Q3 | $2.84M | Buy |
10,421
+65
| +0.6% | +$17.7K | 0.16% | 138 |
|
|
2020
Q2 | $3.01M | Buy |
10,356
+9,580
| +1,235% | +$2.78M | 0.18% | 128 |
|
|
2020
Q1 | $185K | Buy |
776
+118
| +18% | +$28.1K | 0.01% | 428 |
|
|
2019
Q4 | $144K | Buy |
+658
| New | +$144K | 0.01% | 482 |
|